Past Early Career Investigator Lectures
Presidential Assistant Professor, Departments of Bioengineering, Microbiology, and PsychiatryUniversity of Pennsylvania
Lecture followed by Q&A session*Students are encouraged to register in Zoom to ask the speaker questions. Please note that space is limited.
artificial intelligence may help to replenish our arsenal of effective drugs, such as those to treat
bacterial infections. Since their discovery in the early 1900s, antibiotic medicines have saved countless lives, but their extensive use has resulted in some bacteria developing resistance to them—meaning our current antibiotics no longer work to treat some infections. To effectively probe antibiotic design and discovery using
computational approaches, researchers must first program computers to sort through the many characteristics of
molecules and determine which properties optimize
Dr. César de la Fuente has trained a computer to select for molecular structures that interact with bacterial
membranes, leading to artificial antimicrobials that kill bacteria both
in vitro and in
research organisms. Additionally, his lab has applied pattern recognition algorithms to mine the human proteome, identifying thousands of possible antibiotics encoded in
proteins throughout the human body. His research group has also used computational tools to successfully reprogram venoms into potential novel antimicrobials.
Dr. César de la Fuente, a Presidential Assistant Professor at the University of Pennsylvania, leads the Machine Biology Group, which aims to combine the power of computers and biology to help prevent, detect, and treat infectious diseases. He received his Ph.D. in microbiology and immunology from the University of British Columbia and then worked as a postdoctoral associate at the Massachusetts Institute of Technology (MIT). Dr. de la Fuente has an NIGMS
Maximizing Investigators’ Research Award grant supporting his work combining chemical and computational tools for predictive models of
microbiome communities. He has received wide recognition for his pioneering research that spans over 100 publications, including the
MIT Technology Review naming him one of the world’s top innovators for “digitizing evolution to make better antibiotics,” the Langer Prize, the Princess of Girona Prize, and the American Society for Microbiology Award for Early Career Applied and Biotechnological Research.
Cesaro A, Torres MDT, Gaglione R, Dell’Olmo E, Di Girolamo R, Bosso A, Pizzo E, Haagsman HP, Veldhuizen EJA,
de la Fuente-Nunez C, and Arciello A. Synthetic antibiotic derived from sequences encrypted in a protein from human plasma.
ACS Nano. (2022) doi: 10.1021/acsnano.1c04496.
Torres MDT, Melo M, Crescenzi O, Notomista E, and
de la Fuente-Nunez C. Mining for encrypted peptide antibiotics in the human proteome.
Nature Biomedical Engineering. (2022) doi: 10.1038/s41551-021-00801-1.
Connect With Us: